Skotnicki A B, Jabłoński M J
Kliniki Hematologii Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.
Przegl Lek. 1996;53(11):826-9.
Thrombopoietin (TPO) is a newly identified hematopoietic growth factor, that stimulates both megakaryopoiesis and thrombopoiesis through its interaction with a specific cell surface receptor (c-Mpl), a member of hematopoietic receptor superfamily, encoded by the c-mpl proto-oncogene. Recently the Janus kinases and STAT proteins have emerged as important elements in signaling via this family of receptors. The complete gene for human thrombopoietin has been cloned and mapped. TPO is believed to be the major physiological regulator of circulating platelet levels and it is hoped that this hormone will be valuable in stimulating megakaryocyte and platelet recovery in patients with thrombocytopenia, just as erythropoietin and GM-CSF or G-CSF have been valuable in stimulating the production of red and white cells.
血小板生成素(TPO)是一种新发现的造血生长因子,它通过与特定细胞表面受体(c-Mpl)相互作用来刺激巨核细胞生成和血小板生成,c-Mpl是造血受体超家族的成员,由c-mpl原癌基因编码。最近,Janus激酶和STAT蛋白已成为通过该受体家族进行信号传导的重要元件。人血小板生成素的完整基因已被克隆和定位。TPO被认为是循环血小板水平的主要生理调节因子,人们希望这种激素在刺激血小板减少症患者的巨核细胞和血小板恢复方面具有重要价值,就像促红细胞生成素和GM-CSF或G-CSF在刺激红细胞和白细胞生成方面具有重要价值一样。